Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial

Annals of Oncology 2026 Open access

Read full text
Authors: Olivia Pagani, Samuel M. Niman, Monica Ruggeri, Fedro A. Peccatori, Hatem A. Azim, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna Barbro Sætersdal, Judith R. Kroep, Ellen Warner, Frédéric Amant
+27 more Audrey Mailliez, Halle C.F. Moore, Manuel Ruiz-Borrego, Janice M. Walshe, Virginia F. Borges, Andrea Gombos, Akemi Kataoka, C. Rousset-Jablonski, Simona Borstnar, Junko Takei, Jeong Eon Lee, Christobel Saunders, Vesna Bjelic-Radisic, Snezana Susnjar, Fatima Cardoso, Natalie Klar, Teresa Ferreiro, Karin Ribi, Kathryn J. Ruddy, Roswitha Kammler, Sarra El-Abed, Giuseppe Viale, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, Richard D. Gelber, Ann H. Partridge
DOI: 10.1016/j.annonc.2026.05.699
Cited by: 4
References: 48

Fields of Study & Subjects

Cancer Risks and Factors Breast Cancer Treatment Studies Advanced Breast Cancer Therapies

Publication details

Journal / source
Annals of Oncology
Publisher
Elsevier BV
Volume
37
Issue
9
Pages
1230–1241
Publication date
29 May 2026
Language
EN